Ever Source Wealth Advisors, LLC Tango Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 26,631 shares of TNGX stock, worth $232,754. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,631
Previous 26
102326.92%
Holding current value
$232,754
Previous $0
Infinity%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNGX
# of Institutions
124Shares Held
117MCall Options Held
245KPut Options Held
18.9K-
Trv Gp Iv, LLC Boston, MA16.9MShares$147 Million97.21% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$93.8 Million11.21% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$92.9 Million4.69% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.16MShares$80 Million0.21% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$52.7 Million0.18% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $770M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...